Back
Brainstorm Cell Therapeutics Stock Price Chart
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now
Sell
43
BCLI
Brainstorm Cell Therapeutics
Last Price:
$1.17
Seasonality Move:
62%
7 Day Trial
ALL ACCESS PASS
$
7
One Tool. Personalized Setups.
Try it here.-
The current trend is relatively stagnant and BCLI is experiencing slight selling pressure.
Brainstorm Cell Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.14 | Buy |
| 20-day SMA: | 1.18 | Sell |
| 50-day SMA: | 1.16 | Sell |
| 200-day SMA: | 1.69 | Sell |
| 8-day EMA: | 1.15 | Buy |
| 20-day EMA: | 1.16 | Buy |
| 50-day EMA: | 1.19 | Sell |
| 200-day EMA: | 2.31 | Sell |
Brainstorm Cell Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 49.99 | Sell |
| Chaikin Money Flow: | -19386 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.1 - 1.22) | Sell |
| Bollinger Bands (100): | (1.01 - 1.55) | Sell |
Brainstorm Cell Therapeutics Technical Analysis
| Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Brainstorm Cell Therapeutics Stock
Is Brainstorm Cell Therapeutics Stock a Buy?
-
Brainstorm Cell Therapeutics share price is 1.16 while BCLI 8-day simple moving average is 1.14, which is a Buy signal.
-
The stock price of BCLI is 1.16 while Brainstorm Cell Therapeutics 20-day SMA is 1.18, which makes it a Sell.
-
Brainstorm Cell Therapeutics 50-day simple moving average is 1.16 while BCLI share price is 1.16, making it a Sell technically.
-
BCLI stock price is 1.16 and Brainstorm Cell Therapeutics 200-day simple moving average is 1.69, creating a Sell signal.
BCLI Technical Analysis vs Fundamental Analysis
Sell
43
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy or a Sell?
-
Brainstorm Cell Therapeutics stock is rated a SellThe current Brainstorm Cell Therapeutics [BCLI] share price is $1.16. The Score for BCLI is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Brainstorm Cell Therapeutics Stock Info
Market Cap:
9.2M
Price in USD:
1.16
Share Volume:
96.9K
Brainstorm Cell Therapeutics 52-Week Range
52-Week High:
6.45
52-Week Low:
0.72
Sell
43
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Brainstorm Cell Therapeutics Share Price Forecast
-
What is the Brainstorm Cell Therapeutics stock price today?The Brainstorm Cell Therapeutics stock price is 1.16 USD today.
-
Will BCLI stock go up or go down?Brainstorm Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Brainstorm Cell Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Brainstorm Cell Therapeutics is overvalued.
Is Brainstorm Cell Therapeutics Stock a Buy?
-
Brainstorm Cell Therapeutics share price is 1.16 while BCLI 8-day exponential moving average is 1.15, which is a Buy signal.
-
The stock price of BCLI is 1.16 while Brainstorm Cell Therapeutics 20-day EMA is 1.16, which makes it a Buy.
-
Brainstorm Cell Therapeutics 50-day exponential moving average is 1.19 while BCLI share price is 1.16, making it a Sell technically.
-
BCLI stock price is 1.16 and Brainstorm Cell Therapeutics 200-day simple moving average is 2.31, creating a Sell signal.
Fundamental Analysis of Brainstorm Cell Therapeutics
Is Brainstorm Cell Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.23 per share, an increase this year of $0.50 per share, and an increase next year of $0.16 per share.
Technical Analysis of Brainstorm Cell Therapeutics
Should I short Brainstorm Cell Therapeutics stock?
-
BCLI Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Brainstorm Cell Therapeutics is a Sell
-
Brainstorm Cell Therapeutics Relative Strength Index (RSI) is 49.99, which suggest Brainstorm Cell Therapeutics is oversold
-
The Bollinger Bands (25) for Brainstorm Cell Therapeutics is (1.1 - 1.22), which suggest Brainstorm Cell Therapeutics is a Sell
-
The Bollinger Bands (100) for Brainstorm Cell Therapeutics is (1.01 - 1.55), which suggest Brainstorm Cell Therapeutics is a Sell
* Brainstorm Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.